Tuesday, October 04, 2011 7:53:03 AM
http://www.sentisearch.com/
SentiSearch has obtained an exclusive worldwide license in certain intellectual property from the Trustees of Columbia University in the City of New York. In addition, we possess our own patents and patent applications.
The Company’s intellectual property assets are primarily based on the work of Dr. Richard Axel, who was awarded the 2004 Nobel Prize in Medicine, and who is a Scientific Consultant to the Company.
With an extension of funding to Columbia from the Foundation for the National Institutes of Health (FNIH) through the Grand Challenges in Global Health Initiative of the Bill and Melinda Gates Foundation, SentiSearch has continued to maximize the potential of Dr. Axel’s work. In 2010, SentiSearch and Bayer CropSciences entered into a research and development agreement to screen Bayer’s extensive library of compounds in a search for the identification of new molecules targeting odorant receptors in insects.
This collaboration includes work performed in Professor Axel’s laboratory at Columbia University funded through the Grand Challenges in Global Health Initiative. One of the main goals of this initiative is to improve the control of insects that affect human health, with the ultimate eradication of malaria, dengue fever, and other insect-borne diseases in the developing world.
In addition to possible benefits in the field of public health, our activities with Bayer could also result in innovative products with a new mode of action capable of preventing damage to agricultural crops caused by insects.
In addition, we continue to explore other commercial applications of our intellectual property assets, including in mosquito repellents to be sold by household product companies, as well as applications in the areas of food production and pharmaceuticals.
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM